Akihiko Shimomura
Juntendo University(JP)National Center for Global Health and Medicine(JP)National Institute for Japanese Language and Linguistics(JP)Center for Global Health(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study(2017)477 cited
- → Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study(2019)366 cited
- → Novel combination of serum microRNA for detecting breast cancer in the early stage(2016)358 cited
- → RETRACTED ARTICLE: Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression(2019)289 cited
- → Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer(2017)158 cited
- → First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors